Yalun Li Selected Research

Yalun Li Research Topics

Disease

21	Neoplasms (Cancer) 12/2021 - 09/2014
13	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2018
11	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2019
10	Neoplasm Metastasis (Metastasis) 12/2021 - 09/2014
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 09/2014
5	Carcinogenesis 01/2022 - 01/2020
5	Lung Neoplasms (Lung Cancer) 08/2021 - 01/2014
3	Adenocarcinoma of Lung 01/2022 - 01/2019
3	Pain (Aches) 01/2020 - 07/2009
3	Carcinoma (Carcinomatosis) 03/2019 - 04/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2021 - 01/2017
2	Lymphatic Metastasis 01/2021 - 04/2015
2	Infections 01/2020 - 10/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2017 - 01/2017
2	Adenocarcinoma 03/2017 - 01/2017
2	Infertility (Sterility) 01/2012 - 07/2009
2	Endometriosis 01/2012 - 07/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2022
1	Liver Neoplasms (Liver Cancer) 11/2021
1	Hypoxia (Hypoxemia) 01/2021
1	COVID-19 01/2021
1	Anemia 01/2020
1	Osteomalacia 01/2020
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2020
1	Abdominal Aortic Aneurysm 01/2020
1	Muscle Weakness 01/2020
1	Pleural Tuberculosis 07/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Intestinal Obstruction (Obstruction, Intestinal) 10/2018
1	Sarcopenia 10/2018

Drug/Important Bio-Agent (IBA)

6	Long Noncoding RNAIBA 01/2022 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2017
5	Messenger RNA (mRNA)IBA 10/2022 - 01/2019
5	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
4	human ERBB2 proteinIBA 01/2021 - 04/2015
3	Proteins (Proteins, Gene)FDA Link 08/2022 - 11/2020
3	6-methyladenineIBA 01/2022 - 01/2020
3	CrizotinibIBA 01/2022 - 01/2019
3	Estrogen ReceptorsIBA 01/2019 - 04/2015
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 04/2015
2	N-methyladenosineIBA 01/2022 - 11/2021
2	Gefitinib (Iressa)FDA Link 01/2022 - 01/2019
2	Immune Checkpoint InhibitorsIBA 12/2021 - 08/2021
2	LipidsIBA 11/2021 - 04/2015
2	Tyrosine Kinase InhibitorsIBA 10/2020 - 01/2020
2	Biological ProductsIBA 01/2019 - 04/2015
2	Pentoxifylline (Trental)FDA LinkGeneric 01/2012 - 07/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2022
1	Phenobarbital (Luminal)FDA Link 08/2022
1	Oxygen (Dioxygen)IBA 03/2022
1	ElectrolytesIBA 03/2022
1	SaltsIBA 03/2022
1	Interleukin-11 (Interleukin 11)IBA 12/2021
1	B7-H1 AntigenIBA 12/2021
1	Hyaluronic Acid (Hyaluronan)IBA 11/2021
1	Cantharidin (Cantharides)IBA 11/2021
1	monomethoxypolyethylene glycol (MPEG)IBA 11/2021
1	Therapeutic UsesIBA 08/2021
1	alectinibIBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 10/2020
1	osimertinibIBA 10/2020
1	Apoptotic Protease-Activating Factor 1IBA 09/2020
1	Internal Ribosome Entry SitesIBA 09/2020
1	Circular RNAIBA 03/2020
1	Small Nucleolar RibonucleoproteinsIBA 01/2020
1	insulin receptor-related receptor (IRR)IBA 01/2020
1	pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Competitive Endogenous RNAIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	MelatoninIBA 01/2020
1	Nicotine FDA Link 01/2020
1	Small Nucleolar RNA (snoRNA)IBA 01/2020
1	AcidsIBA 07/2019
1	Indicators and Reagents (Reagents)IBA 04/2019
1	Annexin A3IBA 03/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2018
1	Urea (Carbamide)FDA LinkGeneric 03/2017
1	Serum AlbuminIBA 03/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2017
1	Keratin-19 (Keratin 19)IBA 01/2017
1	Carcinoembryonic AntigenIBA 01/2017
1	Peptides (Polypeptides)IBA 11/2016
1	arginyllysineIBA 11/2016
1	NeuropilinsIBA 11/2016
1	Neuropilin-1IBA 11/2016
1	LyP-1 peptideIBA 11/2016

Therapy/Procedure

7	Therapeutics 11/2021 - 07/2009
3	Immunotherapy 12/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 11/2021 - 01/2019
1	Neoadjuvant Therapy 03/2019
1	Length of Stay 10/2018